Insights and Stories on Bayer

Jun. 8, 2020 at 8:30 pm CDT

Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those […]

By GFM Staff, Reuters

Jun. 4, 2020 at 1:51 pm CDT

Updated — Reuters — A U.S. appeals court has blocked Bayer from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. A three-judge panel of the Ninth U.S. Circuit Court of Appeals ruled the U.S. […]

By Ludwig Burger, Tom Polansek

May. 25, 2020 at 1:56 pm CDT

Frankfurt | Reuters — Bayer said on Monday it had made progress seeking a settlement over claims its glyphosate-based Roundup herbicide causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases. The drugs and pesticides group is keen to draw a line under […]

By Ludwig Burger

Apr. 15, 2020 at 2:38 pm CDT

Frankfurt | Reuters — Shareholder advisory groups are divided over whether to endorse the management and directors at German drugs and pesticides company Bayer, according to recommendations submitted by proxy voting firms. Bayer is due to host its annual general meeting on April 28 but the company still faces potentially […]

By Reuters

Mar. 13, 2020 at 8:35 pm CDT

Reuters — Bayer has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging that its Roundup herbicide causes cancer, the Wall Street Journal reported on Friday, citing people familiar with the matter. Shares of the German drugs and pesticides company have […]

By Reuters